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The Keap1-Nrf2 pathway regulates a wide range of cytoprotective genes, and has been found to 
serve a protective and beneficial role in many body systems. There is limited information 
available, however, about its role in bone homeostasis. While Nrf2 activation has been suggested 
as an effective method of increasing bone mass and quality, there have been conflicting reports 
which associate Keap1 deficiency with detrimental phenotypes. As Keap1 deletion is a common 
method of Nrf2 activation, further study should address the impacts of various methods of 
regulating Nrf2 expression. Also, little research has been conducted on the specific pathways by 
which Nrf2 activation improves bone quality. In this study, the effects of alterations to Nrf2 
activation levels were explored in two specific and varied scenarios. In the first experiment, 
moderate Nrf2 activation was achieved via partial deletion of its sequestering protein, Keap1, in 
an aging mouse model. The hypothesis tested here is that moderate Nrf2 activation improves 
bone quality by affecting bone metabolism and response to mechanical loading. The results of 
this first experiment suggest a subtle, sex-specific effect of moderate Nrf2 activation in aging 
mice which improves specific indices of bone quality to varying degrees, but does not affect 
loading-induced bone formation. It is likely that the overwhelming phenotypic impacts 
associated with aging or the systemic effects of global Keap1 deficiency may increase the 
difficulty in parsing out significant effects that can be attributed solely to Nrf2 activation. In the 
second experiment, a cell-specific knockout of Nrf2 in the osteocytes was achieved using a 
Cre/Lox breeding system. The hypothesis tested here is that osteocyte-specific deletion of Nrf2 
impairs bone quality by affecting bone metabolism and response to mechanical loading. The 
results of this experiment suggest an important role of Nrf2 in osteocyte function which 
improves certain indices of bone quality, which impacts male and female bones in different 7 
ways, but did not significantly impact loading-induced bone formation. Further studies should 
modify the method of Nrf2 activation in an effort to refine the animal model, allowing the effects 
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of Nrf2 to be isolated from the potential systemic effects of Keap1 deletion. Future studies 
should also utilize other conditional knockout models to elucidate the effects of Nrf2 in other 
specific cell types. 
  
12 
 
INTRODUCTION 
1.1 Bone Biology 
The significance and complexities of bone should never be understated. It is the concerted effort 
of the 206 bones of the adult human skeleton which provide the weight-bearing framework for 
all other tissues [1-3]. Connective tissues attach muscle to bone, empowering the body with 
articulated movement [2, 3]. Protective bone structures such as the ribcage and skull shield 
vulnerable and vital organs. Bone marrow houses immune cells and the hematopoietic stem cells 
which continually replenish the blood cell supply [4]. Bone also serves as a responsive reservoir 
of calcium and phosphate, mediating the delicate balance of minerals in circulation [1, 3]. In 
these ways, bone tissue has supported the evolutionary journey of all vertebrates and is 
indispensable to their success [3]. 
In addition to its many roles in support of other body systems, bone tissue itself is more dynamic 
and communicative than is often recognized. Far from inert, living bone is in a constant state of 
mechanotransduction and remodeling [1, 3, 5-8]. It responds to strain [3]. It heals when damaged. 
It works throughout the life of an organism to maintain a delicate balance which maximizes the 
function and support provided [2, 3, 7, 9]. With ageing or disease, this balance can shift to favor 
resorption [7, 10]. Particularly in women, a loss of cortical – and even more significant loss of 
trabecular bone – is seen correlating to age [10]. This leads to dysfunction or disease of the bone 
tissue including osteoporosis, rheumatoid arthritis, and metastatic cancers [7].  
In the case of osteoporosis, the strength and structural integrity of the bone is diminished through 
a loss of bone mass, leading to increased bone fragility [1]. To the 70 million people with this 
condition, a simple bone fracture can be life-threatening [7]. The musculoskeletal conditions 
resulting from injury, dysfunction, and ageing of bone tissue are the most commonly reported 
chronic medical conditions in adults in the United States. The medical costs associated with 
osteoporotic fractures is projected to reach $25.3 billion in the USA by the year 2025 [11]. While 
hip fractures represent the most common life-threatening fracture in osteoporosis patients, even 
minor fractures (such as vertebral, rib, or wrist fractures) have been linked to increased mortality 
rates [12, 13]. This type of injury is often followed by extended periods of decreased physical 
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activity, chronic pain, decreased muscle mass, and reduced quality of life [13]. This can initiate a 
steep decline in health which drastically increases the risk of death in following years [13]. 
Although the economic and social impacts of bone disease are immense, the precise underlying 
mechanisms of osteoporosis development have not been fully understood [1]. The 
microarchitecture and composition of subchondral bone has also been linked to osteoarthritis, a 
leading cause of disability [14]. Furthering the understanding of the specific molecular 
mechanisms which dictate the delicate homeostasis of bone strength is essential to finding 
specific and effective therapeutic targets for treatment and prevention of bone disorders [1]. 
1.2 Bone Tissue Structure 
The unique composition and qualities of bone tissue set it apart from most other tissues, and 
unraveling its complexities has been the goal of investigators for over 300 years [1, 15]. It is 
comprised of an organic phase embedded with mineral crystals [5]. The balance of these 
components determines the strength and mechanical properties of bone [2]. Immature bone is 
flexible and collagenous, slowly mineralizing over the course of development into mature bone 
[16]. Mature bone exists in a fluctuating state, maintaining a delicate balance of stiffness (as 
bone must provide weight-bearing strength) and flexibility (as excessive rigidity or brittleness of 
bone results in damage upon weight bearing) [2, 3]. Mature bone tissue is generally divided into 
two forms: the cortical (or compact) bone and the trabecular (also known as cancellous) bone, 
which possess unique microarchitecture [5].  In order to address the network of intricacies which 
allow the vast functions of bone to be carried out continuously, it is best to understand the 
composition and structure on a hierarchical scale [15]. 
1.2.1 Bone Composition 
Bone tissue is a matrix of biopolymers, mineralized to varying degrees with calcium 
hydroxyapatite crystals (Ca10(PO4)6(OH)2) [2, 4, 5, 17]. The organic phase of bone is primarily 
type I collagen, but also includes other noncallagenous proteins (NCPs) associated with the 
matrix, like osteocalcin, osteonectin, osteopontin, proteogloycans and glycoproteins [4, 9]. Only 
around 15% of these NCPs are located within bone cells, and the rest occupy the extracellular 
matrix [9]. While they make up only a small fraction of the matrix, these noncollagenous 
proteins serve important functions [17]. Several glycoproteins take part in mineralization of 
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newly-formed bone, proteoglycans support cartilage and skeletal development, soteocalcin 
regulates mineral homeostasis, and osteonectin promotes formation and mineralization of new 
bone tissue [9] 
The impressive tensile strength and flexibility of bone is owed to the triple helix conformation of 
its large proportion of collagen, reinforced with cross-links that maintain structure while 
absorbing mechanical loads [2, 5]. While human bone, on average, is about 60 percent 
mineralized; the degree of bone mineralization varies with function, from stiff high fidelity 
structures like the auditory ossicles (around 90 percent mineralized) to shock-absorbing and 
relatively flexible structures like antlers (only around 40 percent mineralized) [2]. All bone 
shares the fundamental building block of the mineralized collagen fibril, and variations in the 
structure and composition of bone on a micro and macro scale determine its function and as a 
whole [15, 16]. The level of strength and resistance to fracture determined by the vast composite 
of variables within bone is referred to as bone quality, and is determined by a combination of 
structural qualities including: bone turnover rate, bone architecture, intrinsic properties, and 
accumulated microdamage [9]. 
1.2.2 Bone Microstructure 
The most fundamental building block of bone is a single mineralized collagen fibril [15]. On a 
microstructural level, bone can be categorized by the method of depositing these fibers [9]. In 
lamellar bone, they are slowly and neatly arranged into discrete visible sheets [9]. On the other 
end of this spectrum, woven bone is a haphazard arrangement of rapidly mineralized and 
disorganized fibers [9]. Bone that is newly formed where no previous bone existed is referred to 
as primary bone, while bone that is deposited where bone has previously been resorbed is called 
secondary bone.  
Primary bone microarchitecture is also separated based on morphology into three categories: 
primary lamellar bone, a strong and dense series of laminar sheets with minimal vasculature 
located on bone surfaces; plexiform bone (also referred to as fibrolamellar bone), a quick-
forming composite of lamellar and nonlamellar bone woven with a network of vasculature; and 
primary osteons, which form by filling in a vascular channel within an established bone with 
concentric layers of new bone [9]. Secondary bone forms after the resorption of original bone 
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tissue and develops a network of canals now known as haversian systems, first described in the 
late seventeenth century in some of the earliest utilizations of the light microscope [18, 19]. The 
tunnels formed by resorption are known as lacunae, while the new bone which fills them is 
referred to as a secondary osteon, first characterized by Gebhardt in more accurate detail after the 
emergence of the polarizing microscope in the nineteenth century [15]. These haversian systems 
generate porosity in the bone, and the patterning of these microstructures determines the strength, 
rigidity, and mass of the bones, all of which heavily factor into the mobility and fitness of an 
organism [7, 9].  
Damage can also be seen and influenced at the microscopic level of bone tissues. Microdamage 
occurs as a result of the repetitive load bearing normally carried out by bone [9]. This damage 
first presents as microcracks – but if it accumulates faster than can be repaired by the bone 
reformation system, fractures become more likely [9]. As a microcrack progresses through solid 
bone, it has trouble penetrating the cement line of an osteon (due to the tightly packed concentric 
layers of bone oriented at a different angle than the surrounding bone) [2]. In this way, the osteon 
structure plays a direct role in resisting detrimental effects of microdamage.  
1.2.3 Bone Macrostructure 
On a macroscopic scale, mature bone is divided into two categories: cortical (or compact) bone, 
and cancellous (also referred to as trabecular or spongy) bone [4, 9]. Cortical bone is the strong, 
protective, largely solid (only around 3-5% porous) bone material which makes up the diaphyses 
and skull [2, 9]. Cortical bone provides rigid strength which allows for mobility and impressive 
weight-bearing ability, but is susceptible to fracture [2]. Cancellous bone, first described by 
Monro [16], is formed from interconnected plates and rods of bone with lamella oriented roughly 
parallel to the trabecular surface [9]. Cancellous bone is primarily found in the ribs, vertebrae, 
and metaphyses of the long bones [9].  
The complete bone structure is formed by a combination of cancellous and cortical bone 
surrounding the bone marrow [4]. The outer surface of the cortical bone is referred to as the 
periosteal surface, and the inner surface which faces the marrow cavity if referred to as the 
endosteal or endocortical surface [2]. Bone formation on the periosteal surface increases the bone 
width, while increases in bone length are achieved through endosteal bone formation [2]. 
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Combined with mineral composition, the micro- and macro-structural properties define the 
strength and quality of a bone. The organization, size, and number of trabeculae within 
cancellous bone are impactful factors in bone quality. This is where the most impactful effects of 
aging are seen in the bone, as trabecular density decreases significantly with age [10]. 
1.3 Bone Cells 
1.3.1 Osteoclasts 
Osteoclasts are large, multinucleated bone cells with the highly specialized function of bone 
resorption [1, 3, 9]. Being exclusively responsible for resorption, osteoclasts are a key factor in 
bone homeostasis (both modeling and remodeling) [4, 9]. Osteoclastogenesis is the process by 
which mature osteoclasts are derived from hematopoietic stem cells (HSCs) in the bone marrow 
[1, 3, 4]. After the HSCs become multipotent progenitors, a subset will further differentiate into 
common myeloid progenitors (CMPs) – and it is these CMPs that give rise to the 
monocyte/macrophage lineage cells which include osteoclast precursors [3, 9]. Certain 
environmental factors – such as calcium gradients, interleukin-3 (IL-3), granulocyte-macrophage 
colony-stimulating factor (GM-CSF), and macrophage colony-stimulating factor (M-CSF) – 
induce these monocyte/macrophage lineage cells to be recruited towards the bone service, 
proliferate, and become differentiated through a series of steps into committed osteoclast 
precursors [9]. Committed osteoclast precursors are RANK+ and can be activated by receptor 
activator of nuclear factor Κ-B ligand (RANKL), a member of the tumor necrosis factor receptor 
family of ligands  [1, 3, 9].  
The activation of RANK by its ligand initiates a signaling cascade involving many cytoplasmic 
factors and downstream signaling pathways, including: TNF receptor-associated factor 6 
(TRAF6), TNF1, c-Fos, NF-KB, IL-1, PGE2, TGFi, inhibitor of NF-ȔB kinase (IKK), c-Jun N-
terminal kinase (JNK), p38, extracellular signal-regulated kinase (ERK) and Src pathways [3, 7, 
20]. RANKL has been identified as the most important factor in this highly-involved process of 
differentiation culminating in expression of the master transcription factor of osteoclastogenesis, 
NFATC1, which induces the fusion of osteoclast precursors and structural changes associated 
with the formation of mature osteoclasts (the completion of osteoclastogenesis) [3, 7, 20].  
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Several unique and dramatic morphological changes occur during osteoclastogenesis [21]. A 
number of precursor cells fuse through a remodeling of the phospholipids within their cell 
membranes [3]. Any of these cells containing 3 or more nuclei are considered mature osteoclasts 
[9]. While most contain 3-20 nuclei, it is common to see even more in a single cell (although 
there appears to be an ideal size for resorption within the average range, as the largest osteoclasts 
have been shown to have reduced bone resorbing activity) [9]. The large size of these cells 
allows them to cover and resorb a wide area of the bone surface quickly and efficiently [3]. The 
actin cytoskeleton also rearranges, generating a polarization within the cell that results in the 
formation of opposing apical and basolateral functional domains [7, 9]. This polarization is a key 
step which allows the osteoclast to attach to and migrate along the bone surface while resorbing 
bone [9]. At the interface of the apical domain and bone surface, the osteoclast forms a firm 
attachment to the bone surface known as the sealed compartment (or sealing zone), within which 
bone resorption occurs [4, 7, 9].  
The sealed compartment surrounds another structure, a convoluted membrane of transport 
vesicles fused to the apical membrane that is known as the ruffled border [9]. The area between 
these two borders allows for the exchange of materials between the osteoclast and the sealing 
zone [9]. Protons generated by carbonic anhydrase and hydrolytic enzymes including cathepsin 
K (CtsK) and matrix metalloproteinases (MMPs) are pumped across the ruffled border to acidify 
this extracellular compartment and degrade the bone matrix [3, 4, 22]. Chloride ions are pumped 
back across the border as a counterbalance to the proton secretion [9]. This acidification 
dissolves the inorganic components of the bone matrix, while the enzymes degrade the organic 
components [3, 4]. The products of resorption are then internalized from the sealing zone into the 
osteoclast and may be transported to lysosomes for degradation or released through the 
basolateral surface into circulation [7, 9]. This process results in the successful degradation and 
resorption of the underlying bone, leaving behind a cavity in the bone surface [5]. Upon 
completion of resorption, osteoclasts are known to undergo apoptosis, although the exact 
mechanisms underlying this process are not completely understood [9]. 
While degrading the bone matrix may sound detrimental, it is actually a vital step in healthy 
bone homeostasis. Bone resorption during development allows for the shaping of growing bones 
and excavation of the marrow cavity [2]. In adults, osteoclasts are recruited to sites of damage, 
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where they excavate damaged bone tissue while simultaneously releasing growth factors (like 
TGF-β) that initiate the migration of osteoblasts which refill the cavity with new bone matrix [1, 
2]. The key to healthy bone homeostasis is balance within these systems [2]. The importance of 
maintaining an appropriate level of RANK/RANKL activity has been demonstrated by several 
studies – while the presence of RANK is absolutely necessary for normal bone homeostasis, its 
constitutive activation has been linked to several bone diseases [3]. Skewing the balance in favor 
of osteoclast activity reduces bone mass and increases bone fragility, while downregulating 
osteoclast activity results in increased bone mass and a reduced damage repair mechanism 
through reformation – with a drastic shift in either direction being linked to various bone 
diseases [2, 3, 9]. This makes the osteoclast an excellent target for the treatment of diseases 
linked to excessive bone resorption [20]. 
Of all the factors involved in the recruitment of osteoclasts, studies have shown that two, M-CSF 
and RANKL, are necessary and sufficient to induce osteoclastogenesis [3, 9, 21]. There are two 
commonly used models for studying osteoclastogenesis, the bone marrow macrophages (BMMs) 
and RAW 264.7 cells. These two cell types have the ability to differentiate into osteoclasts for 
use as study models, but a study by Ng et al found that RAW 264.7 cells undergo 
osteoclastogenesis even in the absence of M-SCF, suggesting that these cells may not be the 
ideal model of the in vivo osteoclast (which is M-CSF-dependent) especially when studying any 
downstream functions associated to M-CSF [21]. 
1.3.2 Osteoblasts 
While bone matrix is dissolved and resorbed by the osteoclasts, new bone tissue is deposited by 
another cell type – the osteoblast [1, 5]. Osteoblasts are mesenchymal cells derived from 
precursors of neural crest or mesodermal origin [8]. Once recruited, active osteoblasts localize on 
the bone surface and secrete osteoid, a material composed type I collagen and other bone matrix 
proteins [4, 23]. They also mediate the mineralization of this newly formed osteoid through the 
secretion of matrix vesicles and alkaline phosphatase [1, 4]. Osteoblasts possess receptors for 
several hormones, including estrogen, vitamin D, parathyroid hormone (PTH) and parathyroid-
related protein (PTHrP) [1]. As the main producer of RANKL, osteoblasts direct osteoclast 
recruitment and work in coordination with osteoclasts to carry out bone reformation [1, 8]. 
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The osteoblast lineage refers to any cell that has ever committed to osteoblast differentiation; 
from committed precursor cells with the potential to become osteoblasts, to currently active 
bone-forming osteoblasts, to lining cells which no longer produce osteoid but appear to guard the 
bone surface, to osteocytes which were once active osteoblasts before becoming embedded in the 
osteoid or mineralized matrix [23]. Recruitment of precursor cells to proliferate near the bone 
surface is mediated by the cytokines insulin-like growth factor-I (IGF-I) and transforming 
growth factor beta (TGF-β) [4]. Contingent upon the activity of bone transcription factor Runt-
related transcription factor 2 (Runx2), they also express matrix metalloproteinase-14 (MMP-13) 
in response to TGF-β1[22]. The precise molecular pathway to the differentiation into mature 
osteoclasts has not been comprehensively defined, but has been shown to involve the cytokines 
bone morphogenetic protein (BMP) and Wnt (a portmanteau of the previously-given names 
Wingless and Int-1), and to be dependent on the presence of the transcription factors Runx2 and 
Osterix (Osx) [4, 8, 23]. Frizzled and sclerostin are known Wnt antagonists that have been shown 
to inhibit osteoblast differentiation [4]. 
Osteoblasts have been extensively researched, given that increases in their activity result in 
increased bone formation and a potential for therapeutic mediation of bone diseases [1, 23]. 
These cells can be readily identified in tissue sections as they associate closely with the bone 
matrix (and are easily distinguishable in size and nucleus number from osteoclasts), but are 
difficult to quantify from in vitro studies lacking osteoid structures [23].  
1.3.3 Osteocytes 
Occassionally, mature osteoblast cells become embedded in an unmineralized, fluid filled lacuna 
within the osteoid they produce [2, 4, 24]. These cells develop into a third type of bone cell – the 
osteocyte [2, 4]. This happens regularly enough that no point within any bone is more than a 
handful of micometers from a lacuna containing an osteocyte [2, 24]. The osteocyte has a unique 
structure, with dendrites that extend outwards through small channels called canaliculi that 
connect to other lacunae, creating a lattice throughout the bone [3, 24]. Focal adhesions anchor 
the osteocytes in place within the lacunae, and the dendrites conect with those of adjacent 
osteocytes at gap junctions [3, 24]. They are the longest lived, most numerous, and yet least 
researched of all bone cells [2]. 
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The osteocyte is thought to be the mechanosensitive cell of bone tissue, and to coordinate the 
activities of osteoblasts and osteoclasts in response to mechanical strain [3, 4, 24]. The precise 
underlying mechanism by which osteocytes communicate strain and command the other bone 
cells has not been fully explained [3]. It is believed that they sense mechanical strain via fluid 
shear stress exerted on the cell membrane during mechanical loading of the bone [10, 24]. While 
this force effect would only occur at one instance upon continuous static loading, its  magnitude 
would increase proportionately with the frequency of dynamic loading (which offers a probable 
explanation for reported findings that only dynamic loading results in increased bone formation) 
[24]. In response to mechanical stress, osteocytes communicate with other osteocytes through 
secreted paracrine signals or through calcium signals at the gap junctions between their dendrites 
[24]. They have been found to be responsive to signaling factors involved in bone formation, 
such as PTH, and to produce signaling factors which directly influence the activity of osteoblasts 
and osteoclasts [4, 24]. Osteocytes are the primary constitutive source sclerostin, an important 
indirect inhibitor of osteoblast activity [4, 24]. Mechanical loading reduces sclerostin expression, 
which in turn increases osteoblastic activity [24]. Osteocytes also produce RANKL which  
activates osteoblasts who in turn secrete RANK that stimulates osteoclast activation [1, 4]. In this 
way, the osteocyte is equipped to coordinate the activities of the whole basic multicellular unit 
(BMU) responsible for bone remodeling to shape and mold the bone structure overall in response 
to mechanical signals [4]. It is very likely that the death of an osteocyte is commounicated 
through changes in molecular signalling to effectively announce a site of significant damage 
within a bone, and this could be an underlying mechanism behind the quick targeted repair of 
bone fractures [2]. 
1.3.4 Other Cell Types 
Several other cell types exist in close association with the three primary bone cell types. 
Chondrocytes are the cells responsible to the production and maintenance of cartilage, and are 
located around the bone extracellular matrix and within the bone marrow that also houses B 
cells, T cells, macrophages, hematopoietic cells, and stromal cells [4]. 
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1.4 Bone Cell Communication 
Because bones respond so specifically to stimuli, it is clear that there must be methods of 
communication driving the appropriate responses. Several avenues of potential molecular 
communication have been studied, describing the significance of paracrine signals in bone cell 
function [2, 23]. Bone tissue is also remarkably innervated, so neuropeptide signalling has been 
studied extensively and subsequently linked at least five distinct neuropeptides (calcitonin gene-
related peptide, neuropeptide Y, substance P, vasoactive intestinal peptide, and tyrosine 
hydroxylase) to a shift in bone homeostasis which favors formation over resorption [25]. 
Although the act of remodeling bone, through the resorption of old bone and deposition of new 
osteoid, is carried out by the basic multicellular unit consisting of the osteoclast and osteoblast, 
this cannot be the true origin of this process [2]. In order to coordinate the activity of these cells 
in direct response to stimulus such as mechanical strain or damage acumulation, there must be 
participants which sense the stimulus and communicate instructions for the appropriate response 
of other participants [2]. This master coordinator is believed to be the osteocyte [2, 4]. These 
three cell types are likely in close communication facilitated by paracrine signaling and gap 
junctions, as evidenced by previous studies demonstrating the necessity of cell-cell contact in 
order for osteoblasts to function properly [23, 25]. The importance of gap junction intercellular 
communication (GJIC) for proper function of osteoblasts and osteocytes has been specifically 
demonstrated [25]. 
Other cell types, such as marrow stromal cells and T cells have been identified as members of the 
communicative network that drives bone remodeling, as have factors such as BMPs, TGF-β, and 
Smad family molecules [7, 25]. 
1.5 Bone Metabolism 
Bone metabolism is the general term for the various complex alterations bone tissue undergoes 
throughout a lifetime [1]. It can be divided into the initial construction of bone, known as 
modeling; and the dynamic reconstruction of existing bone, known as remodeling [2, 26]. Both 
are cellular processes by which the size, shape, and architecture of the bone are changed [2, 26]. 
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1.5.1 Bone Modeling 
Bone modeling is the method of initial formation of new bone onto an existing bone surface 
where none had previously existed, which occurs during growth and development [2, 9]. The 
term also applies to osteoclastic resorption that is not coupled with osteoblast activity [9]. This is 
the method by which growing bones elongate and change shape, and is regulated by several 
interacting factors in the microenvironment [2, 4, 5, 9]. Since bone modeling always takes place 
on existing bone surface,  the initial ossification of cartilagenous structures into embryonic bones 
is not considered modeling [9]. While the modeling process is principal to regular vertebrate 
development, its underlying molecular mechanisms are not fully known [27]. A few members of 
the expansive network of biomolecules and growth factors interacting in this process include: 
PTHrP, Runx2, Osx, MBP, and Hedgehog signaling [5, 25, 27]. 
1.5.2 Bone Remodeling 
In contrast to bone modeling, remodeling is a change in existing bone resulting from the coupled 
activities of bone resorption and formation carried out by the basic multicellular unit (BMU) of 
osteoclast and osteoblast [1, 7, 9, 20]. A third type of cell with a poorly understood function, the 
lining cell, is laid along the sites of osteoclast excavation between resorption and formation (a 
phase referred to as the reversal phase). It is this tightly-coupled process that makes the precise 
replacement of resorbed bone with newly-formed bone possible, thereby removing old or 
damaged tissue continuously without sacrificing bone quality [5, 8]. This process maintains the 
integrity of the adult skeleton and is the primary source of any morphological changes that occur 
in the bones throughout the adult life of an organism [9]. Remodeling can also be utilized for the 
release of minerals into circulation in the case of a mineral deficiency [1].  
The repeating cycles of osteoclastic resorption and paired osteoblastic formation maintain a 
balance which allows the skeleton to carry out its protective and locomotive functions 
throughout the lifetime of the organism [2, 3]. Any shifts in this balance can be detrimental to 
bone health; and some, such as those associated with ageing, appear inevitable in long-lived 
species [1, 2]. Rapid remodeling results in an increase in the proportion of immature bone tissue, 
which is more susceptible to fracture than more mineralized bone [2]. Because trabecular 
structures have significantly greater surface area proportional to mass, trabecular bone turns over 
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much faster than cortical bone [2]. A decrease in osteoblast activity, as is commonly seen with 
ageing, causes disequilibrium in the BMU that decreases overall bone mass [5].  
Sophisticated signaling directs the process of bone remodeling, insuring not only that specific 
damaged or stressed sites receive focused attention; but that the osteoclasts are always recruited 
first, to clear the way before the osteoblasts refill the gaps [2, 9]. Signals released into the 
microenvironment from all three bone cell types are likely in communication during initiation [2]. 
The osteocyte directs the initiation of remodeling to sites of damage or strain, where osteoblasts 
and osteoclasts are recruited and form a feedback loop which promotes their activity [2]. The 
various factors involved include Wnts [8], TGF-β, MMP-13, Runx2 [22], and other hormones, 
cytokines, matrix proteins, and growth factors [8]. 
1.6 Skeletal Mechanotransduction 
Mechanotransduction is the ability to detect mechanical signals and transduce them into 
physiological responses [10, 28-30]. The term can be strictly defined as the conversion of 
mechanical energy into chemical energy; and, within biological systems, this refers to the ability 
of living tissues to respond to sensed mechanical stimuli from the environment [30]. The study of 
mechanotransduction in bone originated with Julius Wolff, an anatomist and surgeon who first 
suggested that bone remodels in response to physical load bearing (this concept linking 
mechanotransduction with bone homeostasis became known as Wolff’s Law) [30]. The 
understanding of bone mechanotransduction has been greatly increased thanks to advancements 
in molecular and cellular biology, allowing specific investigations into the signaling pathways 
involved in this process [30]. 
Many body tissues change or remodel in response to detection of mechanical strain. The 
previous decade of research has demonstrated that this potential exists in all cell types, and is not 
limited to cell types with well-known adaptations for sensory transduction (such as neurons or 
the hair cells of the ear) [10, 30]. It is apparent that the mechanisms behind mechanotransduction 
are complex, and several cellular components have been suggested as possible sites of 
mechanotransduction, including: cell-matrix adhesions, cell-cell adhesions, the cytoskeleton, cell 
membranes, and extracellular environment [10, 29, 30]. Intercellular and extracellular filaments 
form a woven network that serves as the basic unit of load bearing in all cell types [30]. 
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Because bone serves a primary function of supportive load-bearing in the body, it is no surprise 
that mechanotransduction plays a significant role in bone homeostasis. Mechanical loading 
initiates a signaling process (referred to as activation) which allows the bone tissue to selectively 
remodel, increasing formation while simultaneously suppressing resorption [10, 24, 26]. This 
response is localized to the area of mechanical strain, and can be reversed if that area enters a 
prolonged state of disuse [24]. The results of this response can be clearly illustrated in human 
models when comparing the dominant and non-dominant arm bones of college baseball players, 
with the dominant arm bones containing over 60% more mass as a result of the selective and 
repetitive loading of that arm over time [24]. This response can be replicated using noninvasive 
loading to selectively apply mechanical strain to only one ulna of mice over a period of time [31]. 
It has been shown that dynamic, cyclical loading produces a significant bone formation response, 
but static/stationary continuous loading fails to reproduce the same response [24]. This increase 
in bone mass is an adaptive way for the body to reduce the strain that will be endured by any 
repeated loadings [10]. Increasing the frequency of dynamic loading has been shown to increase 
the bone formation response, up to a plateau of the trend at around 10 Hz [24]. 
Aging may have significant implications in mechanotransduction. In humans, it has been noted 
that bone formation in response to mechanical loading (through physical activity and exercise) is 
greatest in young individuals, and diminished in the elderly [10]. There is limited and conflicting 
information available about the role of aging in mechanotransduction [10]. It has been suggested 
that age may affect mechanotransduction through a reduction in cell sensitivity, a change in 
hormone or paracrine factor levels, or even simply via a decline in the number of viable 
mechanosensitive cells like osteocytes and MSCs [10]. 
The molecular signaling pathways involved in mechanotransduction of living bone are not fully 
known, but involve the release of ATP and calcium ions followed by the actions of messenger 
molecules like prostaglandins, nitric oxide, and protein kinases [24]. Within bone tissues, the 
osteocyte is believed to be the primary mechanosensitive cell type [3, 4, 24, 26]. Osteoblasts and 
osteoclasts are also likely involved in bone signal communication, as they each release 
nucleotides capable of functioning as autocrine and paracrine signaling factors in response to 
mechanical strain [32]. Potential mechanosensors within bone cells include: calcium channels 
(both stretch- and voltage-sensitive), adhesion proteins bound by integrins to the extracellular 
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matrix, and a G protein-coupled receptor (GPCR) [24]. Several osteogenic factors have been 
shown to mediate loading-induced bone formation, including prostaglandins, nitric oxide, TGF-β, 
and insulin-like growth factors [28, 32]. 
1.7 The Keap1-Nrf2 Interaction 
1.7.1 Stress Response 
Cellular stress has many origins and products. Natural processes can result in stress. Stress can 
also result from exogenous sources like drugs, pollutants, and food additives. These foreign 
substances are referred to as xenobiotics. Biological systems manage stress through the process 
of detoxification, which occurs in two phases. Phase I detoxification involves the breakdown of 
xenobiotics into electrophiles, metabolites that still have deleterious potential [33]. True 
detoxification occurs during phase II detoxification, where these intermediates are metabolized 
into non-toxic products [33]. 
Xenobiotics contribute to the redox reactions which produce reactive oxygen species (ROS) [34]. 
However, ROS also form as a natural byproduct of cellular function [35]. While elevated ROS 
levels result in oxidative stress and cell damage, it has been firmly established that ROS are 
required, at least in small amounts, to maintain normal cellular function [28, 35, 36]. The 
dilemma faced by all aerobic eukaryotes is that oxygen, while ubiquitous and vital, poses 
inherent threat (this is called the “oxygen paradox”) [35]. This threat has been building for over 2 
billion years, ever since the reservoir of organic matter on the planet became fully saturated with 
oxygen produced by the newly evolved photosynthetic cyanobacteria and excess oxygen 
accumulated – likely leading to the first mass extinction of anaerobic organisms unable to cope 
with the changing atmosphere [37]. Methods of maintaining the appropriate balance of ROS in 
biological systems include antioxidants and free radical scavengers. The Keap1-Nrf2 pathway is 
responsible for a key cytoprotective transcriptional cascade which combats oxidative stress of 
many sources including xenobiotics, ROS, radiation, and endogenous stressors [38-40]. 
1.7.2 Nrf2  
Nuclear factor erythroid 2-related factor 2 (Nrf2), first characterized in 1994, is a transcription 
factor considered a master regulator of antioxidant cytoprotective genes [1, 41, 42]. It is a 
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member of the basic leucine zipper family of proteins – along with the ubiquitously expressed 
Nrf1, the placenta- and liver- specific Nrf3; and NF-EF, which is only expressed in erythrocytes 
[1]. Nrf2 is the primary mediator of redox stress in the basic leucine zipper family, and is 
ubiquitously expressed [1, 43]. Under unstressed conditions, Nrf2 is maintained in the 
cytoplasm, bound to its repressor Kelch-like ECH-associated protein 1 (Keap1) [43]. When 
activated, Nrf2 mediates a powerful signaling cascade necessary for phase II detoxification 
involving several antioxidant, cytoprotective, and detoxifying enzymes [33, 39]; which has been 
demonstrated in an abundance of disease models including cancer, diabetes, and liver disease 
[44, 45]. Nrf2 activity has been a highly popular topic of investigation for the past two decades 
[39], which has resulted in significant revelations of the molecular mechanisms behind its 
cytoprotective cascade [1]. 
Along with its basic leucine zipper domain, Nrf2 also contains an N-terminal hydrophobic 
domain, Cap‘n’Collar (CNC) domain, transcriptional activation domain, and a Keap1-binding 
domain [1, 46]. The Keap1-binding domain maintains the association with the repressor Keap1 
under basal conditions [43]. The leucine zipper domain allows heterodimerization with small 
Maf or Jun proteins and binds Nrf2 to an antioxidant response element (ARE) [1]. While the 
bulk of research has focused on the role of Nrf2 as a transcription factor, recent studies have also 
illustrated its importance as a protein whose presence is necessary for certain processes, such as 
angiogenesis [43]. 
High ROS levels pose a threat to many biological systems and contribute to a multitude of 
disease models including cancer, infertility, and neurodegenerative disease [28, 35]. They arise 
from the breakdown of molecular oxygen into atomic oxygen, which has a single unpaired 
electron – making it a free radical [35]. In response to increasing levels of stress molecules 
(electrophiles, ROS, or metabolites of phase I detoxification), Nrf2 is released from its 
sequestering protein, Keap1, and permitted to translocate into the nucleus [1, 40, 43]. There, 
Nrf2 binds to the antioxidant response element (ARE) and increases the expression of 
cytoprotective genes like heme oxygenase 1 (HMOX1), NADPH quinone dehydrogenase 10 
(NQO1), and the glutamate-cysteine ligase modifier subunit (GCLM) [43]. Nrf2 activates 
enzymes necessary for phase II detoxification of ROS and electrophiles into non-toxic products 
[33]. 
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1.7.3 Keap1 
After Nrf2 became a hot topic of broad research, Kelch-like ECH-associated protein 1 (Keap1) 
was discovered during the in-depth analysis of Nrf2 regulation [33]. Its successful discovery was 
first described by Itoh, Mimura, and Yamamoto in 2010 [33]. Keap1 holds Nrf2 by associating 
with its N-terminal domain [1, 33]. Under low stress conditions, Keap1 prevents the 
translocation of Nrf2 to the nucleus and ushers it towards degradation via the ubiquitin-
proteasome pathway mediated by Cul3/Rbx1 [1, 33]. Exposure to stress (detected as xenobiotics, 
ROS, or intermediate products of phase I detoxification) leads to the oxidation of the cysteine 
residues which maintain the attachment to Nrf2, leading to its release [1, 40, 43]. The free Nrf2 
is then translocated to the nucleus for activation and initiation of phase II detoxification. In this 
way, Keap1 acts as a sensor of stress and regulates cellular detoxifying ability accordingly by 
regulating Nrf2 activation [1, 40, 43]. 
Keap1 is a homodimeric protein similar to the Drosophila protein Kelch [33, 40]. It contains two 
canonical protein interaction domains: bric-a-brac tramtrack broad complex (BTB) and Kelch 
(also known as the double glycine repeat or DGR), as well as two other domains: the intervening 
region (IVR) and C-terminal region (CTR) [40]. The BTB domain dimerizes Keap1, allowing 
ubiquitin conjugation to the lysine residues of the N-terminal domain of Nrf2; the DC domain (a 
collective term for the  DGR and CTR) forms the physical interaction with the Nrf2 N-terminal 
domain, and the IVR promotes the ubiquitination of Nrf2 [40] 
1.7.4 Significance of this Pathway 
As a master regulator of cytoprotective and antioxidant function, the Nrf2 pathway is a very 
attractive potential therapeutic target [39, 40, 47]. Various endogenous, environmental, and 
pharmacological inducers have been shown to activate Nrf2 [48]. Some natural activators 
include the isothiocyanates of cruciferous vegetables, organosulfur found in garlic, isoflavanes 
found in beans and coffee, phenols from ginger, and polyphenols from tea. Synthetic activators 
are also available, such as: trivalent arsenicals, dithiolethiones, and oxidizable diphenols [39]. 
The level of interest in boosting Nrf2 activation in humans is understandable, since the Keap1-
Nrf2 pathway mediates the oxidative stress response, innate immunity, and metabolic 
homeostasis [40]. Nrf2 activation is also imperative for the process of drug metabolism via ARE-
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mediated enzyme induction [33]. Nrf2 activation has been shown to increase survival rates 
during sepsis in mice [38]. In the study of some diseases related to oxidative stress, such as 
Alzheimer’s and Huntington’s disease, where the administration of antioxidants as treatment has 
not succeeded; therapeutic alterations to the Keap1-Nrf2 pathway could provide a more effective 
treatment by activating an innate and continuous antioxidant response [47]. Systemic 
hyperactivation of Nrf2, however, has the potential to induce detrimental effects. Previous 
studies have suggested Nrf2 plays a role in chemoresistance, making the treatment of some 
cancers more difficult [36]. Eliminating all of the ROS in a biological system would greatly 
impair vital functions like bone marrow homeostasis [36]. 
1.7.5 Effects of the Keap1-Nrf2 Pathway on Bone 
Being ubiquitously expressed, the Nrf2 signaling pathway has the potential to affect all body 
tissue types, and has recently come into view as a pivotal regulator of bone metabolism [1]. Nrf2 
deficient mice have significantly diminished bone strength and impaired bone formation in 
response to mechanical loading [1]. The loss of mass and strength in Nrf2 deficient mice results 
from an imbalance in bone remodeling, and suggests that the loss of antioxidant function in 
female osteoporotic patients may be linked to the Keap1-Nrf2 pathway [1]. Indeed, deletion of 
Nrf2 has been shown to increase osteoclast number when compared to wild type controls [42], 
and over activation of Nrf2 resulted in increased levels of RANKL and a consequential 
suppression of osteoclast activity [1].  Effective control of Nrf2 activation could be invaluable as 
a preventative measure or therapeutic treatment in bone-related health, as recently illustrated by a 
study by Katsumata et al, which demonstrated that a known Nrf2 activator, epigallocatechin 
gallate (EGCG) inhibits osteoclastic absorption associated with degenerative diseases of the teeth 
and facial bones [49]. This example highlights the importance of maintaining the appropriate 
balance when dealing with Nrf2 activation, as some level of osteoclastic absorption is necessary 
for tooth movement during orthodontic treatment [49]. Another natural Nrf2 activator, gastrodin, 
was recently found to protect against the development of osteoporosis that occurs following 
prolonged glucocorticoid therapy [50]. The inhibitory effect of Nrf2 activation on osteoclast 
activity may result from RANK/RANKL levels, actin ring interference, or interaction with 
NFATc1 [1]. While the bulk of research has been directed at the study of Nrf2 and its effects on 
osteoclast activity, there is controversial data to suggest the Nrf2 may also play a role in 
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osteoblast activity [1, 42]. There may be other systemic impacts of Keap1 deficiency that act 
independently of Nrf2 function, as it has also been suggested recently that Keap1 deficiency may 
have adverse effects on bone metabolism [51, 52]. This could mean systemic Keap1 deficiency is 
not an ideal means of activating Nrf2, or that moderate activation is preferential to extreme cases 
of hyperactivation. Exploring the specific mechanisms at work during Nrf2 signaling provides an 
opportunity to better understand the mechanisms of bone loss, and may identify effective 
therapeutic targets for combating bone diseases [1]. 
1.7.6 Research Goals 
Previous findings indicate that Nrf2 activation increases bone formation. The majority of 
research in this field, however, has used global knockout models of Nrf2 deficiency [1]. The 
goals of this study were to investigate the effects of Nrf2 activity on bone formation through two 
specific circumstances. First, the effects of Nrf2 activation via partial Keap1 knockdown on 
ageing mice were examined; testing our hypothesis that moderate Nrf2 activation improves bone 
quality by affecting bone metabolism and response to mechanical loading. This study provides 
potential insights into considerations that should be taken when treating age-related bone 
diseases such as osteoporosis. Second, the effects of osteocyte-specific deletion of Nrf2 on adult 
mice were investigated; testing the complementary hypothesis that osteocyte-specific Nrf2 
deletion reduces bone quality by affecting bone metabolism and response to mechanical loading. 
The role of Nrf2 in bone homeostasis has thus far been largely limited to the activity of 
osteoclasts [1]. This study provides insight into the role of Nrf2 at the cell population level, with 
regard to the osteocyte – a relatively under-represented cell type.  
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 MATERIALS AND METHODS 
2.1 Experimental Mice 
All animal protocols were reviewed and approved by the Indiana University Animal Care and 
Use Committee (IUACUC). All animals were provided ad libitum access to standard mouse 
chow and fresh water for the duration of the study. Animals were housed in plastic cages at a 
temperature of 22 ± 1 ° C with a daily light cycle from 6:00 AM to 6:00 PM. Dmp1-8kb-Cre 
mice possessing a transgene orienting the cre recombinase sequence downstream of the mouse 
dentin matrix protein 1 (Dmp1) gene with approximately 8 kb of 5’ flanking sequence were 
obtained from IU medical school via Teresita Bellido’s research group according to their 
published protocol [53].  Subjects from a line of mice created by Jingbo Pi’s group with LoxP 
sites flanking the exon of Nrf2 (Nrf2LoxP/LoxP) were obtained via Bobby Thomas of the Medical 
College of Georgia at Augusta University [54]. Keap1 deficient individuals from a strain of 
Keap1 deficient mice were obtained through Riken BRC (No.RBCRC01388). This strain carries 
a targeted mutation replacing Keap1 with a cassette encoding neomycin and nls-lacZ (RIKEN 
BioResource Research Center, Saitama, Japan). All genetics lines used in both studies were 
derived from C57BL/6J mice (Jackson Laboratories, Bar Harbor, ME, USA). 
2.2 Breeding 
The targeted mutation line of Keap1+/- mice is maintained by repeated crosses of Keap1+/- 
animals with C57BL/6J wild-types. This cross generates approximately 50% Keap1+/- offspring 
and 50% Keap1+/+ wild-type littermate controls (Figure 1). Previous analysis of calvarial 
osteoblasts from this breeding scheme confirmed increased expression of Nrf2 in Keap1+/- 
animals (Figure 23, Li 2019). Osteocyte-specific deletion of Nrf2 was achieved using a Cre/Lox 
system of two transgenic lines. Dmp1-8kb-Cre mice (which express Cre recombinase only in the 
presence of Dmp1 expression) were crossed with Nrf2LoxP/LoxP mice (with LoxP sites flankingthe 
exon of both copies of the Nrf2 sequence, generating a hemizygous F1 generation. Breeding 
pairs consisting of two hemizygous mice produce Dmp1-Cre positive offspring. Approximately 
25% of the offspring produced are Nrf2Flox/Flox, conditionally deleting Nrf2 expression in Dmp1+ 
cells (i.e. osteocytes). Another ~25% will be wild-type littermate controls (Nrf2+/+). The 
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remaining 50% are expected to be more hemizygous mice that can be used to maintain the 
colony (Figure 13).  
2.3 Genotyping 
The genotype of each experimental animal was obtained through polymerase chain reaction 
(PCR) amplification of DNA samples. Genotyping was performed after weaning the test animals, 
and repeated after sacrifice for confirmation. DNA was obtained at 3-4 weeks of age through the 
collection of the 1mm ear notch removed for individual identification. The ear punch was 
sanitized between animals with 70% ethanol. At sacrifice, samples were obtained by removing 
the distal 1-2mm of the tail. Scissors were sanitized with 70% ethanol after each tail snip. These 
samples were placed into individually labeled 1.5 mL centrifuge tubes. Samples were processed 
immediately after collection. Lysis buffer consisting of: 50 mM Tris (pH 8), 50 mM KCl, 2.5 
mM EDTA, 40 mM 0.4% NP, 40 mM 0.45% Tween, and 2.5mM  4% Proteinase K (10 mg/mL) 
was mixed immediately prior to use. For tail tip or ear notch samples, 100 µL or 30 µL of this 
lysis buffer was added, respectively. The 1.5 mL centrifuge tubes were then left in a water bath 
at 56°C overnight. The following morning, all tubes were removed from the water bath and 
centrifuged, before being placed into a dry bath at 95°C for 10 minutes in order to denature the 
Proteinase K. The lysates were then diluted with a volume of autoclaved milliQ water equal to 
the volume of lysis buffer used on that sample, resulting in 60µL ear notch lysates and 200µL 
tail-tip lysates. 
PCR mix was prepared using 12.5 µL per sample of GoTaq® Green Master Mix (Promega 
Corporation, Madison, WI, USA) held in PCR certified 0.2 mL centrifuge tubes. For every tube, 
0.5 µL of each appropriate primer was added. When genotyping for Keap1, a set of three primers 
was used. The primers and sequences for amplification of Keap1 were as follows: d132 – 5’- 
CGG GAT CCC CAT GGA AAG GCT TAT TGA GTT C-3’, TVneo – 5’-TCA GAG CAG 
CCG ATT GTC TGT TGT GCC CAG TCA-3’, and intR – 5’-CAG TTT TCC TCC AGC CTG 
TC-3’ (Figure 2). When genotyping for Dmp1 CRE, a set of two primers was used. The primers 
and sequences for amplification of Dmp1 CRE were as follows: forward (CsCre1) – 5’-AGG 
GAT CGC GAG GCG TTT TC-3’ and reverse (CsCre2) – 5’-GTT TTC TTT TCG GAT CCG 
CC-3’ (Figure 14A). When genotyping for Nrf2 LoxP, a set of three primers was used. The 
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primers and sequences for amplification of Nrf2 LoxP were as follows: forward (Nrf2_Loxp1_F) 
– 5’-CAC AAT GGT ATG CCT GCT GT-3’, reverse (Nrf2_LoxP1_R) – 5’-AAG AGG GGG 
TTG GAA AGA GA-3’, and wild-type reverse (Nrf2_LoxP1-WT_R) – 5’-TCT GCA CCA GAG 
TTC AAA GG-3’ (Figure 14B). All primers were obtained through IDT (Integrated DNA 
Technologies, Inc., Skokie, IL, USA). Next, a volume of sterile PCR water was added to each 
tube. In cases when two primers were used, 5.5 µL of water was added. When three primers were 
used, 5.0 µL of water was added. Finally, 1.0 µL of DNA lysate from the appropriate animal was 
added to each tube, resulting in a consistent volume of 20 µL per tube. All tubes were then 
loaded into an Eppendorf Mastercycler® gradient thermal cycler (Eppendorf North America, 
Hauppauge, NY, USA) and run for 40 cycles before a 15°C hold until removal. 
Upon completion of PCR, samples were removed from the thermal cycler and added to a 2.5% 
agarose gel prepared using 1.25 g agarose and 50 mL 0.5x TBE buffer with an added 7 µL of 
SYBR® Safe DNA gel stain (Thermo Fisher Scientific, Waltham, MA, USA). 10 µL of each 
post-PCR sample was added to consecutive wells in the gel, flanked by two wells containing 10 
µL of Quick-Load® 100 bp DNA Ladder (New England Biolabs, Ipswich, MA, USA) for 
reference. Immediately following electrophoresis, the gel was imaged using a Typhoon™ FLA 
9500 laser scanner (GE Healthcare Life Sciences, Marlborough, MA, USA). When genotyping 
animals for Keap1, the presence of a single band at 350 bp indicated a Keap1+/+ individual. The 
presence of a single band at 500 bp would indicate a Keap1-/- individual (however, this 
phenotype is lethal before weaning age and was never observed in this study). The presence of 
both bands (350 bp and 500 bp) indicated a Keap1+/- individual. When genotyping for Dmp1 
CRE, the presence of a band at 300 bp indicated a Dmp1 CRE+ individual. No visible band 
appeared for Dmp1 CRE˗ individuals. When genotyping for Nrf2 LoxP, the presence of a single 
band 180 bp indicated an Nrf2flox/flox individual. The presence of a single band at 210 bp 
indicated an Nrf2+/+ individual. The simultaneous presence of both bands indicated a 
heterozygous individual with only one LoxP site 
2.4 Mechanical Loading 
The loading experiment was initiated at 6 months of age for the Dmp1-Cre, Nrf2-LoxP study; 
and at 18 months of age for the Keap1 heterozygote study group (±14 days). Two weeks prior to 
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sacrifice, animals were subjected to in vivo axial mechanical loading of the right ulnae once a 
day for a duration of 3 days. The axial ulnar loading method established by Torrence et al was 
followed [31]. Thanks to the uniformly curved shape of the ulna, this results in a predictable and 
repeatable pattern of strain applied to the midshaft without damaging the bones [24]. This 
loading method is also preferable to four-point bending as it applies the force far enough from 
the site of strain to eliminate the need for a loading sham group [31]. Instead, the left ulna of 
each animal serves as a non-loaded internal control. Mice were handled according to the protocol 
previously used by this lab [32]. Before each session of loading, animals were anaesthetized via 
inhalation of 2% Isoflurane, USP. The body weight of each individual was recorded. They were 
then situated into a Bose® ElectroForce® Model 3220 mechanical testing system (TA 
Instruments, New Castle, DE, USA), which carried out a set of 120 cycles of mechanical strain 
(2.9 N for males, 2.6 N for females) over the course of 60 seconds. Anesthesia was maintained 
throughout the procedure using a mouse nose cone. This process was repeated each day until 3 
rounds of mechanical bone loading had been completed on each test subject. All animals were 
allowed normal cage activity following loading sessions. Two days following the third and final 
round of loading (9 days prior to sacrifice), 0.2 mL of the green fluorochrome label calcein (30 
mg/Kg body weight) was administered via intraperitoneal injection. Five days later (4 days prior 
to sacrifice), 0.2 mL the red fluorochrome label alizarin (50 mg/Kg body weight) was 
administered via intraperitoneal injection. All test animals were sacrificed 4 days after the 
administration of alizarin. 
2.5 Sacrifice 
All test subjects were euthanized at 6 months of age, after completing the 14-day mechanical 
loading test cycle. In order to obtain a large volume (200-400 µL) blood sample from each 
individual, animals were first deeply anesthetized using Isoflurane, USP. Sacrifice body weight 
was recorded. Submandibular blood specimens were then collected and stored in BD 
Microtainer® blood collection tubes with a serum separating additive (Becton, Dickinson and 
Company, Franklin Lakes, NJ, USA). Anesthesia was maintained as animals were then 
euthanized via cervical dislocation. Following euthanasia, several tissues were harvested and 
processed for storage. The right femur was collected and placed into a glass vial of 10% buffered 
formalin phosphate. The right tibia was collected, wrapped in a saline-soaked gauze pad, and 
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sealed into a small plastic bag. The Left femur was collected and placed into a 1.5 mL centrifuge 
tube. The left tibia was collected and placed into a 1.5 mL centrifuge tube. The spine was 
collected, wrapped in a saline-soaked gauze pad, and sealed into a small plastic bag. The right 
and left ulnae were collected and placed into the glass vial of formalin. Using scissors, the distal 
1-2mm of the tail was snipped and placed in a 1.5 mL centrifuge tube.  
All harvested tissues were then returned to the lab for processing and storage. The blood 
specimens were centrifuged for 10 minutes to separate the serum before storing at ˗80°C. The 
glass vials of formalin containing the right femur and both ulnae were held at 4°C overnight, 
before replacing the formalin with 70% ethanol and returning to storage at 4°C.  Plastic bags 
containing the spine and left femur samples were stored at ˗20°C. Centrifuge tubes containing 
tibiae were stored at ˗80°C. Tail tips were used to prepare DNA lysates for genotype 
confirmation. 
2.6 Biomechanical Testing and Analysis 
The mineral content of the left femur of each test subject was analyzed through dual energy X‐
ray absorptiometry (DXA) using a PIXImus bone densometer (PIXImus Lunar Corp., Madison, 
WI, USA), and each femur was imaged with a SkyScan 1172 microCT (SkyScan, Kontich, 
Belgium) following the protocol previously established [55]. Phantoms were included in each 
scan. After imaging, a four-point bending test was conducted on each femur. Reconstitution of 
3D structure was carried out using NRecon reconstruction software (Micro Photonics Inc., 
Allentown, PA, USA). CTan software was used to select ROI for each midshaft. The trabecular 
ROI was defined as 3mm of the trabecular region of the distal femur beginning 1 mm proximal 
to the growth plate. Reconstructions and four-point bending data were then analyzed through 
MATLAB®. Cortical ROIs composed of 7 images each averaging 15 µm of cortical bone surface 
were utilized in this analysis.  
2.7 Histology and Histomorphometry 
From each experimental animal, the following tissues were processed for histological and 
histomorphometric analysis: right femur, right ulna, and left ulna. After dissection, these samples 
were fixed in 10% neutral-buffered formalin (NBF) for 24 hours, followed by storage at 4°C in 
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70% EtOH until the onset of processing. Processing of the samples consists of two stages: 
dehydration and infiltration of embedding media. Prior to processing, the femora and ulnae were 
cleaned of remaining external soft tissue. The radii were removed from all left ulnae, while right 
radii were left intact to facilitate quick distinction between right and left sections. The left and 
right ulnae from each experimental animal were then wrapped together at the proximal and distal 
ends by looping twice with 36 AWG copper wire. The ulna bundles were measured, and the right 
mid-shaft of each bundle was marked lightly with a pencil. Each completed ulna bundle was 
placed in a labeled tissue cassette and submerged in 70% EtOH. Each right femur sample was 
measured, and the mid-shaft lightly marked with a pencil. The marrow cavity of the distal femur 
was exposed above and below the growth plate by shaving away the patella groove parallel to the 
diaphysis with a #22 scalpel blade. Each femur was then cut 1.5 mm distal to the mid-shaft mark 
using a Buehler® Isomet TM low speed saw (Buehler, Lake Bluff, IL, USA). The distal femur and 
femur mid-shaft sections were then placed in individually labeled tissue cassettes and submerged 
in 70% EtOH.  
Dehydration was achieved by replacing the 70% EtOH immersing solution with a stepwise series 
of EtOHs with concentration being increased every 2-8 hours up to 100% EtOH. Once samples 
were completely dehydrated, the process of infiltration of embedding media was initiated. First, 
the 100% EtOH was replaced with a 1:1 mixture of EtOH and methyl methacrylate (MMA) for 
2-8 hours. Next, this mixture was replaced with undiluted MMA monomer for another 2-8 hours. 
After that, the undiluted MMA was replaced with infiltration media (MMA and 4% dibutyl 
phthalate) and samples were placed under a vacuum for 24 hours at 17 inHg. This was then 
replaced with a freshly mixed volume of infiltration media, and returned to the vacuum at 17 
inHg for another 2-7 days. Upon completion of this step, samples were considered fully 
dehydrated, infiltrated, and ready to embed. 
2.7.1 Ulna Sample Preparation 
Prior to embedding samples, polymerized bases were prepared in labeled 6x50 mm glass culture 
tubes using embedding media (MMA, 4% dibutyl phthalate, 0.8% perkadox). A drill was used to 
create a hole in the center of each polymerized base, which served to hold samples upright in the 
tube during polymerization. These tubes were nearly filled with embedding media, then each 
ulna bundle was placed into the corresponding labeled tube. Tubes were stored in a tube rack to 
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keep them upright; and placed, uncapped, under a vacuum (17 inHg) for at least 20 minutes, 
before being tightly capped with rubber stoppers. Sealed tubes were placed into 1 oz plastic vials 
filled partially with distilled water. These vials were left on a slide warmer at 25° C for 1-2 days, 
then heat cured overnight at 60° C. The glass was removed from the completed MMA tubes 
using a hammer.  
Using a wire saw, 5 sequential transverse thick sections (approximately 50 µm) were collected, 
beginning 2.5 sections before the mid-shaft pencil mark to ensure mid-shaft collection. These 
sections were sonicated to remove sawdust, then left to dry at room temperature overnight.  Dry 
sections were mounted to clean microscope slides using Eukitt® mounting medium 
(MilliporeSigma, St. Louis, MO, USA). A small piece of paper towel was placed between this 
section and a second microscope slide, and a binder clip was used to hold the two slides together 
overnight. The following day, the top slide and paper towel were removed. The mounted section 
was covered in several dropped of xylenes-thinned mounting medium (filling gaps and 
increasing surface area for grinding the section). These slides were left to dry at room 
temperature overnight. Dried coated slides were then ground to a thickness of 30-50 µM. This 
was achieved by holding each slide with a small suction cup and gently sanding, section down, in 
a figure-eight motion against wet 600 grit sandpaper. Ground slides were sonicated in distilled 
water and left to dry overnight. The following day, a glass cover slip was applied to each slide 
using xylenes-thinned mounting medium. After drying overnight, completed slides were stored 
in a slide box. 
2.7.2 Femur Midshaft Slide Preparation 
Preparation of right femur mid-shaft samples closely followed the same protocol used for ulna 
cortical sections. The protocol only differed in the number of sections collected with the wire 
saw. For femur mid-shaft samples, 3 sequential 50 µM transverse sections were collected, 
beginning 1.5 section widths prior to the mid-shaft pencil mark to ensure mid-shaft collection. 
2.7.3 Distal Femur Slide Preparation 
The right distal femur of each test animal was embedded in 1 oz plastic vials using embedding 
media. Prior to adding the samples, bases were polymerized in each vial using 6 mL of 
embedding media. Vials with prepared bases were labeled for each sample and filled with 
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embedding media. Each fully infiltrated distal femur was removed from a tissue cassette and 
quickly placed into the corresponding labeled vial. Uncapped vials were placed in a vacuum (17 
inHg) for at least 2 hours. Vials were then capped tightly and refrigerated at 4° C overnight. 
Further polymerization was carried out at room temperature. The samples, now embedded in 
blocks of MMA, were removed from their molds using a hammer and chisel. 
Blocks of MMA containing embedded distal femora were trimmed and shaped using a saw and 
grinder. Portions of the MMA were cut away in order to form an equiangular rectangle with the 
tissue sample centered 0.5 cm from all sides and flush with the front face of the block. The 
outside edges of the front face of each block were then rounded out with the grinder to reduce 
tears or snags during thin sectioning. Thin sectioning of the finished blocks was carried out on a 
rotary microtome using a tungsten carbide knife. After securing a block to the microtome and 
softening the face with 50% EtOH, a series of 4 µm thick longitudinal sections were taken from 
the block face and transferred to Superfrost® Plus microscope slides subbed with a 1% gelatin 
solution (Thermo Fisher Scientific, Waltham, MA, USA). Five slides were prepared for each 
tissue sample, with each slide containing three sequential sections. After three sections had been 
transferred to a slide, it was flooded with 70% EtOH and each section was gently smoothed with 
a small paintbrush to reduce wrinkles and folds. The slide was then covered in plastic and excess 
EtOH was gently removed by placing bibulous paper over the plastic and rolling across the slide 
with a rubber roller. When a set of five slides had been completed for a sample, the slides were 
sandwiched between two blank microscope slides and secured together with a binder clip. These 
stacks were left to dry overnight at 37° C. The following day, the clips and plastic were removed 
and slides were stored in a slide box. 
2.7.4 Histological Staining 
One slide containing 3 thin trabecular sections of the distal femur of each test subject was TRAP 
stained. This stain can be used as a histologic marker, as all osteocytes express and secrete 
tartrate-resistant acid phosphatase (TRAP) [9]. Toluidine blue was used as a counterstain. Static 
histomorphometry of stained slides was carried out using OsteoMeasureTM histomorphometry 
software (OsteoMetrics, Decatur, GA, USA). Slides were analyzed under bright-field 
illumination on an Olympus DP72 digital microscope camera connected to an Olympus BX53 
Telepathology Microscope System (Olympus Scientific Solutions Americas, Waltham, MA, 
38 
 
USA). Each sample was scored for the following parameters: osteoclast number (N.Oc), 
osteoclast surface (Oc.S/BS), osteoclast number over bone surface (N.Oc/B.Pm), and osteoclast 
number over perimeter (N.Oc.Oc.Pm). 
2.7.5 Dynamic Histomorphometry 
Quantitative analysis of bone samples was achieved using OsteoMeasureTM histomorphometry 
software (OsteoMetrics, Decatur, GA, USA). Slides were analyzed on an Olympus DP72 digital 
microscope camera connected to an Olympus BX53 Telepathology Microscope System 
(Olympus Scientific Solutions Americas, Waltham, MA, USA). Fluorochrome labels were 
visualized through illumination with an X-Cite Series 120Q fluorescence illuminator (Excelitas 
Technologies, Waltham, MA, USA). Measurements were taken on a Wacom touchscreen 
monitor with stylus through the tracing of focused, illuminated sections at 200x magnification 
(Wacom, Kazo, Saitama Prefecture, Japan).  
Unstained cortical sections of the left and right ulnae of each test animal were scored for the 
following direct measurements: periosteal perimeter, endocortical perimeter, periosteal single 
label, endocortical single label, periosteal double label, and endocortical double label. Derived 
measurements including MS/BS, MAR, and BFR/BS were calculated using these primary 
tracings. An unstained right femur midshaft cortical section from each test animal was also 
scored for the same set of parameters as the ulnae.  
Because only the right ulna of each animal was loaded, each left ulna could be used as a non-
loaded control against the reciprocal section from the right ulna. The difference between right 
and left ulna measurements were calculated and referred to as the relative values, which 
represent the amount of metabolic bone activity occurring as a direct result of mechanical 
loading [32]. These relative values illustrate loading-induced bone formation as a measure of 
mechanotransduction. 
Two trabecular sections from the right distal femur of each mouse were scored. One unstained 
section was scored for trabecular surface and fluorochrome labeling, and derived kinetic indices 
including BV/TV, MS/BS, MAR, and BFR/BS were calculated using the direct tracings. A 
TRAP stained section was used to measure osteoclast number, osteoclast surface, and 
proportional trabecular bone surface. 
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2.8 Statistical Analysis 
All data are reported as mean ± standard error of the mean (SEM). Potential outliers were 
identified using the interquartile range method, a resistant method of statistical analysis which 
prevents outliers from skewing overall results [56].  Selected parameters for the identification of 
potential outliers were periosteal BFR and trabecular BV/TV. After investigating potential 
outliers, one sample from the Keap1 aging study was determined to have extremely anomalous 
bone characteristics and was subsequently omitted from statistical analysis. Test groups were 
compared using a two-tailed Student’s t-test of two groups assuming unequal variances using 
Excel software. Significance was determined as p < 0.05. 
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 RESULTS 
3.1 Moderate Nrf2 Activation via Partial Deletion of Keap1 in Aging Mice 
3.1.1 Keap1+/- Mice 
At 18 months of age, study animals were selected from the breeding line described previously. 
After excluding one identified outlier, 2 female Keap1+/+ (WT), 14 female Keap1+/- (HT), 7 male 
Keap1+/+ (WT), and 12 male Keap1+/- (Ht) mice were utilized for statistical analysis. At the start 
of the loading study, female Ht mice weighed less than WT controls (-24% p = 0.008). As WT 
females lost slightly more weight over the course of the study than Ht females, no such 
difference was recorded when comparing the final body weights of Ht and WT females.  All 
mice lost an average of 0.86 grams over the course of the loading study, although none of the 
losses reached significance. While males weighed significantly more than females (+15% p = 
0.003), there were no significant differences in average weight change between HT animals and 
their WT controls. (Figure 3) 
3.1.2 Biomechanical Properties 
Structural and material properties of bone quality were assessed through PIXImus analysis and 
subsequent 4-point bending test of the left femur of each test subject. 
3.1.2.1 PIXImus Analysis 
Keap1+/- female mice were found to have decreased bone mineral density (-13% p = 0.0004) 
versus wild-type females. No genotype specific differences were found between male Keap1+/- 
mice and wild type controls.  Overall, males had 13% higher BMC (p = 0.003) and 7% higher 
BMD (p = 0.01) than females (Figure 6). 
3.1.2.2 Mechanical Testing: 3-Point Bending 
No significant differences were observed between the biomechanical properties of Keap1+/- and 
their wild-type controls for either male or female animals. When examining structural properties, 
female stiffness was 28% higher than that of males (p = 0.004), and male ultimate force was 20% 
higher than that of females (p = 0.005). This did not result in any significant difference in total 
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work between males and females and was not genotype specific. When examining the bone’s 
material properties, females were found to have 44% higher Young’s Modulus compared to 
males (p = 0.0002). No sex or genotype specific differences in toughness or ultimate stress were 
observed (Figures 4-5). 
3.1.2.3 Trabecular analysis 
Trabecular analysis found that Keap1+/- males had significantly higher trabecular numbers than 
WT males. There was no significant difference found between heterozygous and wild-type mice 
in structure model index, trabecular thickness, or trabecular separation. No difference was found 
in overall BV/TV based on either genotype or sex.  Males had higher BV/TV and trabecular 
number than females, while females had greater trabecular separation (Figure 10). 
3.1.3 Histomorphometry 
3.1.3.1 Static histomorphometry 
To investigate levels of resorptive activity on the trabecular surface, TRAP stained thin sections 
of the distal femur were scored. There were no significant differences in osteoclast number 
(N.Oc) observed between Keap1+/- animals and their wild-type controls. Males overall had 
significantly greater numbers of osteoclasts than females (+65% p = 0.006), but this difference 
was not genotype specific. There were no differences observed between Keap1+/- individuals and 
wild-type controls for the parameters of: osteoclast surface (calculated as proportion of bone 
surface), osteoclast number proportional to bone surface, or osteoclast number over perimeter. 
For those three parameters, there was also no significant difference in mean values between 
males and females (Figure 8). 
3.1.3.2 Dynamic histomorphometry 
Fluorescence scoring of thin trabecular sections of the distal femur showed no significant 
differences in MS/BS, MAR, or BFR between Ht animals and WT controls. There was also no 
difference found in these values between males and females. Trabecular BV/TV was 84% higher 
in males than females (p = 2.45 x 10-5), but this difference was not genotype specific (Figure 9). 
Dynamic histomorphometry of cortical left and right ulna sections were used to measure loading-
induced bone formation. No significant differences were observed between Keap1+/- animals and 
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wild type controls regardless of sex for any of the derived indices of: relative MS/BS, relative 
MAR, or relative BFR (Figure 7). 
Unstained cortical sections of the femur midshaft were scored for bone surface as well as 
periosteal and endocortical fluorescent labeling. Ht females had decreased Ct.T.Ar (-13% p = 
0.0003) and Ct.B.Ar (-18% p = 0.006) compared to WT females. However, there was no 
difference in BV/TV between Ht animals and WT controls. Overall, males exhibited higher 
Ct.T.Ar (+9% p = 0.001), Ct.B.Ar (+15% p = 4.22 x 10-5), and BV/TV (+7% p = 0.008) than 
females, but this was not genotype specific. No differences based on genotype or sex were found 
regarding Ps.MS/BS. Ht females had 57% higher Ps.MAR than WT females (p = 0.02). Ht 
females also had increased Ps.BFR/BS compared to WT females (+62% p = 0.03). Females 
overall had higher Ps.MAR (+54% p = 0.02) and Ps.BFR/BS (+60% p = 0.028) than males. No 
differences based on genotype or sex were detected when analyzing Ec.BFR/BS (Figures 11-12). 
3.2 Osteocyte-Specific Deletion of Nrf2 in Adult Mice 
3.2.1 Nrf2 cKO Mice 
Following the Cre-Lox breeding scheme previously described, male and female Dmp1-Cre+, 
Nrf2flox/flox (cKO) as well as Dmp1-Cre+, Nrf2+/+ (WT) controls were obtained and aged to 6 
months. In total, 8 WT female, 15 cKO female, 12 WT male, and 8 KO male mice were utilized 
for this study. When assessing phenotypic differences in these mice, males were found to have 
higher body weights at the onset of the loading study (+17% p = 0.0007) compared to females. 
This 17% increase in weight was consistent with measurements recorded upon completion of the 
study, immediately prior to sacrifice (p = 6.13 x 10-7). There was no significant difference in 
weight between cKO animals and their WT controls, for either females or males. Conditional 
knockout mice were not visually distinguishable from their wild-type controls. Study animals 
lost an average of 0.17 grams over the course of the study. This change was not sex or genotype 
specific (Figure 15). 
3.2.2 Biomechanical Properties 
Structural and material properties of bone quality were assessed through PIXImus analysis and 
subsequent 4-point bending test of the left femur of each test subject. 
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3.2.2.1 PIXImus Analysis 
No differences in BMD were seen between cKO animals and their WT controls for either 
females or males. Male mice exhibited a trend toward lower BMD than that of females, but did 
not reach the level of statistical significance (p = 0.052). Likewise, no genotype specific 
differences were recorded in BMC for either females or males. BMC values recorded were 
consistent between males and females (Figure 18). 
3.2.2.2 Mechanical Testing: 3-point Bending 
No significant differences were observed between the biomechanical properties of cKO animals 
and their wild-type controls for either male or female mice. When examining structural 
properties, female stiffness was 20% higher than that of males (p = 4.5 x 10-8), and female 
ultimate force was 16% higher than that of males (p = 6.99 x 10-5). This did not result in any 
significant difference in total work between males and females and was not genotype specific. 
There was an insignificant trend towards increased total work in cKO females compared to WT 
females. When examining the bone’s material properties, females were found to have 14% 
higher ultimate stress (p = 0.0014) and 19% higher Young’s Modulus (p = 0.008) compared to 
males. No sex or genotype specific differences in toughness or ultimate stress were observed, but 
there was an insignificant trend towards increased toughness in cKO females compared to WT 
females (Figures 16-17). 
3.2.2.3 Trabecular Analysis 
Trabecular analysis revealed that female cKO mice had decreased trabecular thickness than WT 
controls (-13% p = 0.027). No significant differences were found between conditional knockouts 
and wild-type controls in trabecular number, trabecular separation, structure model index, or 
BV/TV. Male mice had higher trabecular number, trabecular thickness, and BV/TV than female 
mice. Females had a higher structure model index (Figure 22). 
3.2.3 Histomorphometry 
3.2.3.1 Static Histomorphometry 
TRAP staining of 4 µm sections of the distal femur of each test animal showed no significant 
differences between cKO and wild-type animals for any of the following parameters: osteoclast 
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number, osteoclast surface over bone surface, osteoclast number over tissue area, osteoclast 
number over bone perimeter, or osteoclast number over osteoclast perimeter. Males overall had 
28% more osteoclasts in total (p = 0.0002), but those osteoclasts were smaller than those of 
female mice (males + 15.4% N.Oc/Oc.Pm, p = 7.14 x 10-5). Females had the greater proportion 
osteoclast surface relative to bone surface (+22% p = 4.02 x 10-6). 
3.2.3.2 Dynamic Histomorphometry 
Dynamic histomorphometry of the distal femur trabeculae revealed that cKO females exhibited a 
33% decrease in MAR (p = 0.04) and a 43% decrease in BFR (p = 0.02) compared to WT female 
controls. Females had significantly higher BFR (+34% p = 0.002) than males. Males had 44% 
greater BV/TV than females (p = 4.4 x 10-7). There was no significant change in BV/TV between 
cKO animals and WT controls (Figures 20-21).  
Relative values of fluorescent labeling (calcein and alizarin) of the high-strain region of cortical 
sections from the midshaft of both left and right ulnae revealed no significant difference in 
rMS/BS, rMAR, or rBFR for either males of females. Male cKO animals neared significance in 
their decreased rMAR (p = 0.0517) and rBFR (p = 0.052). There was also no significant 
difference recorded between male and female relative values (Figure 19).  
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 DISCUSSION 
4.1 Moderate Nrf2 Activation via Partial Deletion of Keap1 
The results of this study suggest a subtle sex-dependent effect of the moderate Nrf2 activation 
resulting from partial deletion of its sequestering protein Keap1 on female bone metabolism, 
which does not impact mechanotransduction. Female Keap1+/- mice weighed less than their wild-
type controls at the onset of this study and were also found to have smaller cortical femur 
midshaft areas than wild-type females. Although their bodies and bones were smaller than those 
of their wild-type counterparts, female Keap1+/- mice had no significant decrease in any 
measured parameter of bone quality.  Female Keap1+/- mice also had 57% higher periosteal 
MAR and 62% higher periosteal BFR/BS than wild-type controls. This suggests that Keap1+/- 
females have increased osteoblast activity which effectively maintains equivalent bone quality 
and strength when compared to wild-type controls, despite their decreased bone size. No 
genotype specific differences were found in any of the following indices: biomechanical 
properties, loading-induced bone formation, osteoclast recruitment or activity, or trabecular bone 
formation. All of these results were unique to females, while male Keap1+/- animals consistently 
showed no significant differences from wild-type males. 
Several differences were observed between male and female mice. Males weighed 15% more 
than females. Males also had larger femur midshaft areas than females, and higher average BMD 
and BMC. When assessing structural properties of bone, females had higher stiffness, and males 
had higher ultimate force. As for the material properties of bone, females were found to have a 
higher Young’s Modulus value. Males had a greater number of osteoclasts than females. Males 
also had 84% higher trabecular BV/TV than females. However, none of these differences were 
genotype specific. 
It is possible that the Keap1+/- model is subject to systemic effects of the global partial deletion 
of Keap1, which may serve as a potential influence on bone metabolism. This would coincide 
with some of the findings of recent studies attributing detrimental phenotypic impacts to Keap1 
deficiency [51, 52]. It is also difficult to determine whether these data illustrate that partial 
Keap1 deletion has no effect on mehcanotransduction, or that any effect was simply 
46 
 
unquantifiable due to the overshadowing effects on aging on mehcanotransduction. Scientific 
opinion regarding the specific effects of aging on mehcanotransduction are widely varied and 
poorly understood [10]. The relative bone formation data recorded following mechanical loading 
suggest that aging may diminish mechanosensitivity, as the wild-type animals used in this study 
exhibited a low response to mechanical loading. However, due to the low loading response of 
wild-type animals, the particular load cell used for this study should be recalibrated before 
repeated trials. Finally, the animal sample used for this study may have been impacted by the 
variations in mortality among Keap1+/- and wild-type mice. 45% of the Keap1 colony died of 
natural causes before reaching 1.5 years of age.  87.5% of the animals lost were wild-types, with 
drastically decreased mortality in the Keap1+/- group. This may have resulted in a control group 
which inadvertently selected for the strongest and healthiest wild-type animals. Studies from this 
lab, with results currently in review, using the same RBRC01388 line of mice have found that 
Keap1 deletion resulted: in increased bone mass (Figure 24, Li 2019), suppressed trabecular 
osteoclast activity (Figure 26, Li 2019), and increased periosteal BFR in adult mice (Figure 25, 
Li 2019). These results were sex specific, with the only significant differences being observed in 
male animals. The divergent results of this current study suggest that aging may introduce 
interacting factors which complicate the Keap1-dependent response. 
4.2 Osteocyte-Specific Deletion of Nrf2 Elicited Mixed Responses in the Bone Metabolism of 
Adult Mice. 
The results of this study suggest an important role of Nrf2 in the osteocyte which affects bone 
metabolism in varied, sex-dependent ways. Conditional knockout (cKO) mice did not show any 
visual differences from their wild-type controls. Males were significantly larger than females 
overall.  Female cKO animals exhibited a significant decrease in trabecular MAR and BFR 
compared to WT controls, suggesting decreased osteoblastic activity in the female conditional 
knockout. In male trabecular sections, MS/BS, MAR, and BFR were consistent between cKO 
and WT animals. Although females had significantly higher rates of bone formation, males 
maintained significantly higher BV/TV than females. There was no genotype specific effect on 
BV/TV for male or female mice. These results suggest that osteocyte-specific deletion of Nrf2 
may inhibit bone formation in females, but not in males.  
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Bone formation following repeated dynamic ulnar loading did not indicate any significant 
change in mechanotransduction based on genotype. 48% of study animals showed no difference 
in MAR between R and L ulnas, suggesting no bone formation response to mechanical loading. 
Because this inconsistency in the data set led to an extremely wide variance of BFR values for all 
four groups of this study, it is not surprising that no statistically significant results were obtained. 
Given the markedly low response to loading, even in wild-type animals, it is possible that 
loading was unsuccessful. Repeated loading studies should be conducted after a recalibration of 
the load cell in order to confirm or deny this possibility. Although no statistically significant 
differences were indicated from these data, cKO male mice appeared to have reduced relative 
BFR which very nearly reached the level of statistical significance (p = 0.052). The statistical 
power of this study could be increased by subsequent trials. 
Deletion of Nrf2 in osteocytes of adult mice impacted several facets of bone metabolism and 
varied widely based on sex. This suggests a possible sex related variable, such as hormone levels, 
could impact the interactions between Nrf2 and the osteocyte. 
4.3 Future Direction of Research 
These studies have provided the basis and motivation for several avenues of future research. The 
results of the aging study on Keap1+/- mice suggest that a global partial deletion of Keap1 may 
not be sufficient to impact bone metabolism or mechanotransduction in advanced age, but that 
moderate activation of Nrf2 does have several relevant effects on bone metabolism. Future 
studies utilizing this mouse model should increase the sample size and allow for significant age-
related mortality, especially of wild-types, in order to increase the statistical power of the results. 
Then, it could be possible to parse out any small impacts of the partial deletion of Keap1 which 
may exist. Another avenue of research should utilize a floxed mouse model with a targeted 
knockout of Keap1 in only a desired tissue of interest. This refined model would likely magnify 
the results by allowing for a complete deletion in one specific tissue rather than a partial deletion 
globally. This method would also enhance future results by eliminating much of the systemic 
effects of global Keap1 deletion that may have interacted with the bone analyzed in this study. 
The effects of Keap1 deletion specific to the osteocyte, osteoblast, and preosteoblasts could be 
explored in this way. 
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APPENDIX  
FIGURES: Study 1 – Partial deletion of Keap1 in aging mice 
 
 
 
 
 
 
Keap1+/- 
Keap1+/- Keap1+/+ 
Keap1+/+ 
Figure 1. Breeding Scheme for Generating Keap1+/- Mice and Wild-Type Littermate 
Controls. (A) RBRC01388 mice with one copy of targeted mutation replacing Keap1 are 
crossed with C57BL/6J wild-type mice, generating Keap1+/- mice and Keap1+/+ (wild-type) 
littermate controls. 
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Figure 2.Keap1 Genotyping. Electrophoresis gel image displaying amplified bands used to 
genotype Keap1+/- animal and wild-type controls. 
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Figure 3. General Characteristics of Keap1 Heterozygotes. Keap1+/- females weighed less 
than WT controls at the onset of the study, but not upon its completion. (A) Initial BW recorded 
immediately prior to the first round of ulnar loading. (B) Final BW recorded immediately prior to 
sacrifice. (C) Relative change in BW (rBW) calculated as the difference between final and initial 
BW. 
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Figure 4. Biomechanical Property Analysis of Keap1 Heterozygotes. (A) Structural properties. 
Nrf2 activation via partial deletion of Keap1 in aged mice did not affect bone stiffness, ultimate 
force, or total work. (B) Material properties. Partial Keap1 deletion had no significant effect on 
Young’s Modulus, toughness, or ultimate stress. Data were collected through a 3-point bending 
test of femora from male and female Keap1+/- (HT) mice and wild-type (WT) controls. 
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Figure 5. 3-Point Bending of Keap1 Heterozygotes. An example (A) Stress/strain curve and (B) 
force/displacement curve illustrating the 3-point bending test of a Keap1+/- mouse femur. 
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Figure 6. PIXImus Analysis of Keap1 Heterozygotes. Group average values for (A) BMD and 
(B) BMC. Data collected from PIXImus mouse densitometer scans of femora from male and 
female Keap1+/- (HT) mice and wild-type (WT) controls. Note that *: p < 0.05. 
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Figure 7. Loading-Induced Bone Formation in Keap1 Heterozygotes. (A) The relative values, 
calculated as the difference between the right (loaded) and left (non-loaded) ulnae were 
calculated to evaluate bone formation activity as a direct result of mechanical loading. (B) 
Example photos of cortical sections of right and left ulnae from all four test groups. Note that: 
white arrows indicate the medial surface of the midshaft, where the highest loading strain is 
applied; bar = 100µm. 
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Figure 8. TRAP Staining Analysis of Keap1 Heterozygotes. TRAP stained thin trabecular 
sections of the distal femora of Keap1+/- (HT) animals were compared to those of wild-type (WT) 
controls. No significant difference was found in any measured parameter including: (A) total 
osteoclast number, (B) osteoclast number proportional to bone surface, (C) osteoclast surface, or 
osteoclast number proportional to osteoclast perimeter. 
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Figure 9. Dynamic Histomorphometry Analysis of Distal Femur Trabeculae in Keap1 
Heterozygotes. Group averages for (A) Trabecular BV/TV and (B) Trabecular BFR. Photo 
examples show trabecular fluorescent labeling in (C) wild-type female, (D) Keap1+/- female, (E) 
wild-type male, and (F) Keap1+/- male mice. Measurements collected from distal femora of male 
and female Keap1+/- mice and wild-type controls. Note that bar = 100µm. 
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Figure 10. Trabecular Analysis of Keap1 Heterozygotes. (A) Trabecular analysis results for 
distal femur of male and female Keap1+/- mice and wild-type controls; accompanied by 3D 
reconstructions of trabeculae from (B) wild-type female, (C) Keap1+/- female, (D) wild-type male, 
and (E) Keap1+/- male mice. Note that *: p < 0.05.  
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Figure 11. Female Keap1+/- Mice Have Significantly Smaller Femur Midshafts than WT 
Females. Average (A) cortical tissue area and (B) cortical bone area of femur midshaft, 
accompanied by photos of example (C) wild-type female, (D) Keap1+/- female, (E) Wild-type 
male, and (F) Keap1+/- male mice. Measurements collected from the femur midshaft of male and 
female Keap1+/- mice and wild-type controls. Note that *: p < 0.05. Bar = 500µm. 
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Figure 12. Dynamic Histomorphometry of Femur Midshaft. Group averages for (A) 
periosteal mineralizing surface, (B) periosteal mineral appositional rate, (C) periosteal bone 
formation rate, and (D) endocortical bone formation rate. Photos illustrate fluorescent labeling of 
(E) wild-type female, (F) Keap1+/- female, (G) wild-type male, and (H) Keap1+/- male mice. Note 
that *: p < 0.05; Bar = 100µm; blue arrows indicate periosteal surface (Ps); yellow arrows 
indicate endocortical surface (Ec). 
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FIGURES: Study 2 – Osteocyte-specific deletion of Nrf2 
 
 
 
Figure 13. Cre/Lox Breeding Scheme for Generating Dmp1Cre, Nrf2LoxP/LoxP Mice with 
Wild-Type (Dmp1-Cre, Nrf2+/+) Littermate Controls. (A) Dmp1-8kb-Cre mice are crossed 
with Nrf2LoxP/LoxP mice. (B) Hemizygous mice are crossed to generate Dmp1-Cre, Nrf2LoxP/LoxP 
conditional knockouts and Dmp1-Cre, Nrf2+/+ controls. 
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Figure 14. Dmp1 Cre and Nrf2 LoxP Genotyping. Electrophoresis gel image displaying 
amplified bands used to genotype (A) Dmp-Cre and (B) Nrf2 LoxP. 
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Figure 15. General Characteristics of Dmp1-Cre+, Nrf2Flox/Flox (cKO) Mice. (A) Initial BW 
recorded immediately prior to the first round of ulnar loading. (B) Final BW recorded 
immediately prior to sacrifice. (C) Relative change in BW (rBW) calculated as the difference 
between final and initial BW. 
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Figure 16. Biomechanical Property Analysis of Dmp1-Cre+, Nrf2Flox/Flox (cKO) Mice. (A) 
Structural properties. Osteocyte-specific deletion of Nrf2 did not affect bone stiffness, ultimate 
force, or total work. (B) Material properties. Conditional knockout also had no significant effect 
on Young’s Modulus, toughness, or ultimate stress. Data were collected through a 3-point 
bending test of femora from male and female Dmp1-Cre+, Nrf2Flox/Flox (cKO) mice and wild-type 
(WT) controls.  
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Figure 17. 3-Point Bending of Dmp1-Cre+, Nrf2Flox/Flox (cKO) Mice. An example (A) 
Stress/strain curve and (B) force/displacement curve illustrating the 3-point bending test of a 
Dmp-Cre+, Nrf2Flox/Flox mouse femur. 
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Figure 18. PIXImus Analysis of Dmp1-Cre+, Nrf2Flox/Flox (cKO) Mice. No significant 
differences in either (A) BMD or (B) BMC were observed between cKO animals and their WT 
controls. Statistical significance was determined using a two-tailed Student’s t-test. 
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Figure 19. Loading-Induced Bone Formation of Dmp1-Cre+, Nrf2Flox/Flox (cKO) Mice. (A) 
The relative values, calculated as the difference between the right (loaded) and left (non-loaded) 
ulnae were calculated to evaluate bone formation activity in the high-strain region of the ulna as 
a direct result of mechanical loading. (B) Example photos of cortical sections of right and left 
ulnae from all four test groups. Note that: white arrows indicate the medial surface of the 
midshaft, where the highest loading strain is applied; bar = 100µm. 
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Figure 20. Results of Dynamic Histomorphometry on Dmp1-Cre+, Nrf2Flox/Flox (cKO) Mice. 
Group averages for (A) mineralizing surface, (B) mineral appositional rate, (C) bone formation 
rate, and (D) proportional bone volume. Measurements collected from distal femora of male and 
female Dmp1-Cre, Nrf2Flox/Flox mice and wild-type controls showed decreased MAR and BFR in 
cKO males compared to wild type controls. Statistical significance was determined using a two-
tailed Student’s t-test. Note that *: p < 0.05. 
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Figure 21. Fluorescent Labeling of Dmp1-Cre+, Nrf2Flox/Flox (cKO) Mice. Photos of 
representative examples of thin section fluorochrome labeling on trabeculae from (A) wild-type 
female, (B) cKO female, (C) wild-type male, and (D) cKO male mice. Note that bar = 100µm. 
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Figure 22. Trabecular analysis of Dmp1-Cre+, Nrf2Flox/Flox (cKO) Mice. Results collected 
from left femora of male and female Dmp1-Cre+, Nrf2Flox/Flox and wild-type controls. Note that *: 
p < 0.05.  
0
5
10
15
20
WT cKO WT cKO
M
ea
n
♀ ♂
BV/TV
0
1
2
3
4
5
WT cKO WT cKO
M
ea
n
♀ ♂
SMI
0
2
4
6
8
WT cKO WT cKO
M
ea
n 
(µ
m
)
♀ ♂
Tt. Thickness
*
0
0.01
0.02
0.03
WT cKO WT cKO
M
ea
n
♀ ♂
Tt. Number
0
5
10
15
20
WT cKO WT cKO
M
ea
n 
(µ
m
)
♀ ♂
Tt. Separation
71 
 
FIGURES: Data acquired from previous studies in this lab 
 
 
 
 
 
 
 
 
   
(adapted from Li manuscript in review) 
Figure 23. Nrf2 Activation Follows Keap1 Deletion. Previous data from this lab acquired via 
real-time PCR of calvarial osteoblasts from Keap1+/+ (WT) Keap1+/- (Ht) and Keap1-/- (KO) mice 
confirming Keap1+/- animals have moderate activation of Nrf2. Note that: Ht or KO vs. WT, ***: 
p<0.001. 
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(Adapted from Li manuscript in review) 
Figure 24. Keap1 Heterozygotes have greater Trabecular BV/TV. Bone volume and structure 
in Keap1 WT and Ht mice. Results show increased BV/TV, decreased trabecular spacing, and 
increased trabecular number in Ht males compared to WT males. Accompanying these figures 
are µ-CT images of distal femur trabecular bone of (A) male WT, (B) male Ht, (C) female WT 
and (D) female Ht. Note that *: p<0.01 vs. WT. 
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(adapted from Li, manuscript in review) 
Figure 25. Keap1 Heterozygotes Show Increased Loading-Induced Bone Formation. 
Dynamic histomorphometry of midshaft femur cortical sections accompanied by photos of the 
fluorescent labels (calcein and alizarin) in (A) male WT, (B) male Ht, (C) female WT, and (D) 
female Ht. Cortical bone formation is increased in male Ht mice compared to wild-type controls. 
Note that *: p < 0.05 and **: p = 0.01; blue arrows indicate periosteal surface (Ps); yellow 
arrows indicate endocortical surface (Ec). 
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(Adapted from Li, manuscript in review) 
Figure 26. Keap1 Heterozygotes Have Decreased Osteoclast Activity. TRAP staining analysis 
of distal femur trabecular bone, accompanied by photos of TRAP stained trabeculae from (A) 
male WT,  (B) male Ht, (C) female WT, and (D) female Ht. Results show significantly decreased 
osteoclast number, osteoclast surface, and serum CTX in male Ht mice vs. WT controls. Note 
that *: p < 0.05. Bar = 100µm. 
  
0
10
20
30
40
Male Female
Oc
.S
/B
S *
WT Ht
0
5
10
15
Male Female
N.
Oc
/B
.P
m
*
WT Ht
0
5
10
15
20
Male FemaleSe
ru
m
 C
TX
  (
ng
/m
L)
WT Ht
*
D C 
B A 
75 
 
REFERENCES 
1. Sun, Y.X., et al., Role of Nrf2 in bone metabolism. J Biomed Sci, 2015. 22: p. 101. 
2. Seeman, E. and P.D. Delmas, Bone quality- the material and structural basis of bone 
strength and fragility. The New England Journal of Medicine, 2006(21): p. 2250. 
3. Ono, T. and T. Nakashima, Recent advances in osteoclast biology. Histochemistry & Cell 
Biology, 2018. 149(4): p. 325-341. 
4. Okamoto, K., et al., Osteoimmunology: The Conceptual Framework Unifying the Immune 
and Skeletal Systems. Physiological Reviews, 2017(4): p. 1295. 
5. Sukhodub, L.F. and K.d.p.s.e.u. Dyadyura, Design and Fabrication of Polymer-Ceramic 
Nanocomposites Materials for Bone Tissue Engineering. Проектування та виготовлення 
полімер-керамічних нанокомпозитних матеріалів для інженерії кісткової тканини, 
2018. 10(6): p. 6003-1-6003-11. 
6. Jast, J. and I. Jasiuk, Age-related changes in the 3D hierarchical structure of rat tibia 
cortical bone characterized by high-resolution micro-CT. Journal of Applied Physiology, 
2013. 114(7): p. 923-933. 
7. Boyle, W.J., W.S. Simonet, and D.L. Lacey, Osteoclast differentiation and activation. 
Nature, 2003. 423(6937): p. 337. 
8. Pederson, L., et al., Regulation of Bone Formation by Osteoclasts Involves Wnt/BMP 
Signaling and the Chemokine Sphingosine-1-Phosphate. Proceedings of the National 
Academy of Sciences of the United States of America, 2008. 105(52): p. 20764. 
9. Burr, D.B. and M.R. Allen, Basic and Applied Bone Biology, ed. D.B.B.M. Allen. Vol. 1. 
2014, 225 Wyman Street, Waltham, MA 02451, USA: Elsevier. 390. 
10. Silva, M.J., Skeletal aging and osteoporosis. [electronic resource] : biomechanics and 
mechanobiology. Studies in mechanobiology, tissue engineering and biomaterials: v. 5. 
2013: Springer. 
11. Burge, R., et al., Incidence and economic burden of osteoporosis-related fractures in the 
United States, 2005-2025. 2007. p. 465-475. 
12. Bliuc, D., et al., Mortality Risk Associated With Low-Trauma Osteoporotic Fracture and 
Subsequent Fracture in Men and Women. JAMA, 2009. 301(5): p. 513-521. 
76 
 
13. Ioannidis, G., et al., Relation between fractures and mortality: results from the Canadian 
Multicentre Osteoporosis Study. CMAJ: Canadian Medical Association Journal = Journal 
De L'association Medicale Canadienne, 2009. 181(5): p. 265-271. 
14. Zuo, Q., et al., Characterization of nano-structural and nano-mechanical properties of 
osteoarthritic subchondral bone. BMC Musculoskeletal Disorders, 2016. 17(1): p. 367. 
15. Reznikov, N., R. Shahar, and S. Weiner, Bone hierarchical structure in three dimensions. 
Acta Biomaterialia, 2014. 10(9): p. 3815. 
16. Monro, A., The anatomy of the human bones, nerves, and lacteal sac and duct. [electronic 
resource] : The ninth edition. By Alexander Monro, Senior, M.D. and F.R.S. fellow of the 
Royal College of Physicians, and professor of Medicine and Anatomy in the University of 
Edinburgh. Eighteenth century collections online. 1777: Printed for J. Balfour. Sold by him 
and other booksellers there. 420. 
17. Chen, F.-M. and X. Liu, Advancing biomaterials of human origin for tissue engineering. 
Progress in polymer science, 2016. 53: p. 86-168. 
18. Leeuwenhoek, A.v., The select works of Antony Van Leeuwenhoek, containing his 
microscopical discoveries in many of the works of nature. Translated from the Dutch and 
Latin editions published by the author, by Samuel Hoole. Part the First. Vol. 2. 1798, 
London: printed by Henry Fry, for the translator, and sold by George Nicol, Bookseller to 
His Majesty, Pall-Mall; J. White, Fleet-Street; J. & A. Arch, Gracechurch Street; and J. 
Wright, Piccadilly. 396. 
19. Havers, C., Osteologia nova: or, some new observations of the bones, and the parts 
belonging to them; with the manner of their accretion and nutrition. 1729, Boston, MA, 
United States: Francis A. Countway Library of Medicine, Harvard University. 
20. Jeong, J.-W., et al., Protective Effects of Fermented Oyster Extract against RANKL-Induced 
Osteoclastogenesis through Scavenging ROS Generation in RAW 264.7 Cells. 2019. 
21. Ng, A.Y.H., et al., Comparative Characterization of Osteoclasts Derived From Murine 
Bone Marrow Macrophages and RAW 264.7 Cells Using Quantitative Proteomics. 2018. 
22. Arumugam, B., et al., Characterization of Runx2 phosphorylation sites required for TGF-
β1-mediated stimulation of matrix metalloproteinase-13 expression in osteoblastic cells. 
Journal Of Cellular Physiology, 2018. 233(2): p. 1082-1094. 
77 
 
23. Tonna, S. and N.A. Sims, Talking among ourselves: paracrine control of bone formation 
within the osteoblast lineage. Calcified Tissue International, 2014. 94(1): p. 35-45. 
24. Turner, C.H., et al., Mechanobiology of the Skeleton. 2009. 
25. Ma, W.H., et al., Neuropeptide Y, substance P, and human bone morphogenetic protein 2 
stimulate human osteoblast osteogenic activity by enhancing gap junction intercellular 
communication. Brazilian Journal of Medical and Biological Research, 2015(4): p. 299. 
26. Robling, A.G., A.B. Castillo, and C.H. Turner, BIOMECHANICAL AND MOLECULAR 
REGULATION OF BONE REMODELING. Annual Review of Biomedical Engineering, 
2006. 8(1): p. 455-498. 
27. Wang, M., et al., Periosteal PTHrP regulates cortical bone modeling during linear growth 
in mice. 2014. p. 71-82. 
28. Hsieh, H.-J., et al., Shear-induced endothelial mechanotransduction: the interplay between 
reactive oxygen species (ROS) and nitric oxide (NO) and the pathophysiological 
implications. Journal of Biomedical Science, 2014. 21(1): p. 1-33. 
29. Zhou, T., et al., Endothelial Mechanotransduction Mechanisms for Vascular Physiology and 
Atherosclerosis. Journal of Mechanics in Medicine & Biology, 2014. 14(5): p. -1. 
30. Tschumperlin, D.J., Mechanotransduction. Comprehensive Physiology, 2011. 1(2): p. 1057-
1073. 
31. Torrance, A.G., et al., Noninvasive loading of the rat ulna in vivo induces a strain-related 
modeling response uncomplicated by trauma or periostal pressure. Calcified Tissue 
International, 1994. 54(3): p. 241-247. 
32. Li, J., et al., The P2X7 Nucleotide Receptor Mediates Skeletal Mechanotransduction. 
Journal of Biological Chemistry, 2005. 280(52): p. 42952-42959. 
33. Itoh, K., J. Mimura, and M. Yamamoto, Discovery of the Negative Regulator of Nrf2, Keap1: 
A Historical Overview. Antioxidants & Redox Signaling, 2010. 13(11): p. 1665-1678. 
34. Pagano, G., Redox-modulated xenobiotic action and ROS formation: a mirror or a window? 
Human & Experimental Toxicology, 2002. 21(2): p. 77-81. 
35. Bardaweel, S.K., et al., Reactive Oxygen Species: the Dual Role in Physiological and 
Pathological Conditions of the Human Body. The Eurasian Journal of Medicine, 2018(3): p. 
193. 
78 
 
36. Yen, C.-H. and H.-H. Hsiao, NRF2 Is One of the Players Involved in Bone Marrow 
Mediated Drug Resistance in Multiple Myeloma. International Journal Of Molecular 
Sciences, 2018. 19(11). 
37. Manchester, L.C., et al., Melatonin: an ancient molecule that makes oxygen metabolically 
tolerable. J Pineal Res, 2015. 59(4): p. 403-19. 
38. Thimmulappa, R.K., et al., Preclinical evaluation of targeting the Nrf2 pathway by 
triterpenoids (CDDO-Im and CDDO-Me) for protection from LPS-induced inflammatory 
response and reactive oxygen species in human peripheral blood mononuclear cells and 
neutrophils. Antioxidants and Redox Signaling, 2007. 9(11): p. 1963-1970. 
39. Huang, Y., et al., The complexity of the Nrf2 pathway: beyond the antioxidant response. J 
Nutr Biochem, 2015. 26(12): p. 1401-13. 
40. Ichimura, Y., et al., Phosphorylation of p62 Activates the Keap1-Nrf2 Pathway during 
Selective Autophagy. Molecular Cell, 2013. 51(5): p. 618-631. 
41. Moi, P., et al., Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper 
transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin 
locus control region. 1994. 
42. Sun, Y.X., et al., Deletion of Nrf2 reduces skeletal mechanical properties and decreases 
load-driven bone formation. Bone, 2015. 74: p. 1-9. 
43. Kloska, D., et al., Nrf2 Sequesters Keap1 Preventing Podosome Disassembly: A 
Quintessential Duet Moonlights in Endothelium. Antioxidants & Redox Signaling, 2019. 
30(14): p. 1709-1730. 
44. Chen, Q.M. and A.J. Maltagliati, Nrf2 at the Heart of Oxidative Stress and Cardiac 
Protection. Physiol Genomics, 2017: p. physiolgenomics.00041.2017. 
45. Beyer, T.A., et al., Impaired liver regeneration in Nrf2 knockout mice: role of ROS-
mediated insulin/IGF-1 resistance. Embo j, 2008. 27(1): p. 212-23. 
46. Zenkov, N.K., et al., Mazes of Nrf2 regulation. Biochemistry (Moscow), 2017(5): p. 556. 
47. Bresciani, A., et al., Nuclear factor (erythroid-derived 2)-like 2 (NRF2) drug discovery: 
Biochemical toolbox to develop NRF2 activators by reversible binding of Kelch-like ECH-
associated protein 1 (KEAP1). Archives Of Biochemistry And Biophysics, 2017. 631: p. 31-
41. 
79 
 
48. Ajiboye, T.O., M.T. Yakubu, and A.T. Oladiji, Electrophilic and Reactive Oxygen Species 
Detoxification Potentials of Chalcone Dimers is Mediated by Redox Transcription Factor 
Nrf-2. Journal of Biochemical and Molecular Toxicology, 2014(1): p. 11. 
49. Katsumata, Y., et al., Single Local Injection of Epigallocatechin Gallate-Modified Gelatin 
Attenuates Bone Resorption and Orthodontic Tooth Movement in Mice. 2018. 
50. Liu, S., et al., Gastrodin protects MC3T3-E1 osteoblasts from dexamethasone-induced 
cellular dysfunction and promotes bone formation via induction of the NRF2 signaling 
pathway. 2018. 
51. Sakai, E., et al., Effects of deficiency of Kelch-like ECH-associated protein 1 on skeletal 
organization: A mechanism for diminished nuclear factor of activated T cells cytoplasmic 1 
during osteoclastogenesis. FASEB Journal, 2017. 31(9): p. 4011-4022. 
52. Yoshida, E., et al., Hyperactivation of Nrf2 leads to hypoplasia of bone in vivo. Genes to 
Cells, 2018(5): p. 386. 
53. Bivi, N., et al., Cell autonomous requirement of connexin 43 for osteocyte survival: 
consequences for endocortical resorption and periosteal bone formation. 2012. 
54. Xue, P., et al., Adipose Deficiency of Nrf2 in ob/ob Mice Results in Severe Metabolic 
Syndrome. 2013. 
55. Blazek, J.D., et al., Disruption of bone development and homeostasis by trisomy in Ts65Dn 
Down syndrome mice. 2010. 
56. Moore, D.S. and G.P. McCabe, Introduction to the practice of statistics. 1989: W.H. 
Freeman. 790. 
 
 
 
 
